Global WholeHealth Partners Corp (OTC: GWHP), as Mentioned in the S1 Filing of July 2020, has Begun to Drawdown on the up to $100,000,000 in Equity Funding According to the Purchase Agreement with EMC2
July 19, 2021 07:00 ET
|
Global WholeHealth Partners Corp.
Global WholeHealth Partners Corp is now Funded for Growth and Expansion SAN CLEMENTE, CA, July 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp (OTC:GWHP) through...
Global WholeHealth Partners Corp (GWHP-OTC) Acquires Rights to Distribute & Sell a 3rd COVID-19 Vaccine - Moderna
June 29, 2021 07:00 ET
|
Global WholeHealth Partners Corp.
Moderna Generated $1.94 Billion in Revenue During the First Quarter, with $1.73 Billion Coming from Its COVID-19 Shot Company Now Has the Rights to Distribute & Sell Three of the Most Popular...
Global WholeHealth Partners Corp. (GWHP-OTC) Acquires Rights to Distribute & Sell Johnson & Johnson COVID-19 Vaccine
June 14, 2021 06:30 ET
|
Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, June 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a company that offers one of the largest lines of COVID 19 tests, including...
Global WholeHealth Partners Corp. (OTC:GWHP) Partners with Nunzia Pharmaceutical Inc., Opening New Avenues of Revenue and Products for Global
April 22, 2021 07:00 ET
|
Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests attains...
Alzheimer's Diagnostics a Medical Breakthrough Attained by Global WholeHealth Partners Corp. (OTC: GWHP) as a Leading Researcher, Believes an Alzheimer's Test Will Save Lives
April 19, 2021 06:30 ET
|
Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains...
Aeterna Zentaris Increases Previously Announced Bought Deal Offering of Common Shares to $29.7 Million
February 16, 2021 22:00 ET
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and...
Aeterna Zentaris Announces $10.0 Million Bought Deal Offering of Common Shares
February 16, 2021 17:19 ET
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and...
Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg
February 02, 2021 07:30 ET
|
Aeterna Zentaris Inc
- Company secures next step to continue to build-out pipeline of assets - University researchers developed a proprietary and orally active bacterial vaccine platform technology currently undergoing...
Aeterna Zentaris to Present at NobleCon17
January 15, 2021 08:05 ET
|
Aeterna Zentaris Inc
– Live video webcast with CEO, Dr. Klaus Paulini, on Wednesday, January 20th at 12:00 PM ET – CHARLESTON, S.C., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)...
Aeterna Zentaris to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
January 05, 2021 08:05 ET
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing...